No Data
No Data
Press Release: Lantheus Completes Acquisition of Evergreen Theragnostics
Lantheus Completes Acquisition Of Evergreen Theragnostics >LNTH
CytoSite Bio Announces Agreement With Lantheus for Granzyme B Targeted PET Imaging Radiotracer for Immunotherapy Assessment
Returns On Capital Are A Standout For Lantheus Holdings (NASDAQ:LNTH)
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
thoughtful Bat_8163 : i have noticed this company 6 years ago as it merges with Progenics, one of my holdings. Amazing development!